ArticleEuropean journal of gastroenterology & hepatology2020

Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn's disease cohort.

Clas-Göran Af Björkesten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.